News

Albumax has been approved under code B4155 as an enteral product. This approval allows for Medicaid reimbursement of costs for eligible patients using Albumax. Albumax has previously received

The firm also announced that it has recruited Eric Reimer to serve as CEO of CareCentrix, and Steve Shulman and Steve Cosler to join the board of directors.

The Committee for Medicinal Products for Human Use (CHMP) recommendation will be considered by the European Commission, which will deliver its final decision on the granting of marketing

This pivotal multi-center study for the isolated, high dose delivery of the anticancer agent melphalan is led by the National Cancer Institute. Providence, the 10th center to join

In the trial, a total of 76 sputum samples were collected from four groups of patients, healthy individuals that never smoked, heavy smokers with no signs of lung

In a first, pre-development step, Novartis will fund the companies’ joint efforts until the program reaches formal preclinical development. MorphoSys will recognize its share of the funding as

Dr Ramsey has served as president of the University of Louisville since late 2002. Dr Ramsey has earned his PhD in economics from the University of Kentucky. Dale

Dyax has requested priority review, which, if granted, would set a target date of six months from receipt of the completed submission for the FDA to take action

Oramed’s Phase IIa trial is focused on assessing the safety and efficacy of its oral insulin capsule on nine Type 1 diabetes patients. The start of this clinical